Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs placebo in ventilated premature neonates
2023-509247-27-00Phase 3Authorised
- Sponsor
- Centre Hospitalier Intercommunal de Créteil
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in respiratory distress syndrome (RDS), pain and discomfort comparing Dexmedetomidine arm with Placebo arm (2 arms). Primary endpoint: Cumulative opioid dose. Planned start Feb 2026; status: authorised.
02
Drugs
dexmedetomidine
03
Conditions
respiratory distress syndrome (RDS)paindiscomfort
Beyond the preview
Go deeper on 2023-509247-27-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-509247-27-00.